期刊文献+

细胞因子IL-17A与免疫性血小板减少症发病关系的初步研究 被引量:1

Expression of T helper-related cytokines in patients with immune thrombocytopenia
下载PDF
导出
摘要 目的 通过观察免疫性血小板减少症(ITP)患者外周血中辅助性T(Th)细胞相关细胞因子水平的变化,探讨其与ITP发病的关系.方法 应用微量样本多重蛋白定量技术(CBA)检测和比较35例慢性ITP患者和30例健康体检者(正常对照组)外周血中IL-2、IL-4、IL-6、IFN-γ和IL-17A的水平.结果 ITP患者外周血IL-17A水平较正常对照组显著升高,两组IL-17A的水平分别为(6.767±1.066)pg/ml和(1.679±0.253)pg/ml,比较有统计学差异(P<0.01);而患者外周血IL-2、IL-4、IL-6、IFN-γ水平与正常对照组相比均无统计学差异(均P >0.05).血小板计数≥20×10^9/L的患者外周血IL-17A水平为(8.217±1.477)pg/ml,血小板计数< 20×10^9/L的患者外周血IL-17A水平为(5.238±1.490)pg/ml,两者间比较无统计学差异(P>0.05).结论 慢性ITP患者外周血IL-17A水平异常升高,提示Th17细胞和IL-17A可能在ITP的发生、发展中发挥重要的作用. Objective To investigate the levels of T helper cell-related cytokines in peripheral blood of patients with immune thrombocytopenia (ITP). Methods The levels of IL-2, IL-4, IL-6, IFN-γ and IL-17A in peripheral blood of 35 patients with chronic ITP and 30 healthy subjects (control group) were detected with cytometric bead array(CBA) method. Results The level of IL-17A in peripheral blood of patients with ITP was significantly higher than that of control group [(6.767±1.066)pg/ml vs (1.679±0.253)pg/ml, P〈0.01]; while there were no significant differences in the levels of IL-2, IL-4, IL-6 and IFN-γ in peripheral blood between two groups(P 〉0.05). There were no significant differences in IL-17A levels between patients with PLT≥20×10^9/L and those with PLT〈20×10^9/L [(8.217±1.477)pg/ml vs (5.238±1.490)pg/ml, P 〉0.05], Conclusion Increased IL-17A levels in peripheral blood are detected in patients with chronic ITP.
出处 《浙江医学》 CAS 2015年第18期1526-1528,共3页 Zhejiang Medical Journal
基金 浙江省绍兴县科技项目(201201)
关键词 免疫性血小板减少症 TH17细胞 IL-17A Immunethrombocytopenia Th17 cell IL-17A
  • 相关文献

参考文献14

  • 1Cines D B, Bussel J B, Liebman H A, et al. The ITP syndrome:pathogenic and clinical diversity [J], Blood, 2009, 113(26):6511-6521.
  • 2Semple J W5 Milev 丫,Cosgrave D, et al. Differences in serum cy-tokine levels in acute and chronic autoimmune thrombocytopenicpurpura: relationship to platelet phenotype and antiplatelet T一cellreactivity[J]. Blood, 1996,87(10):4245-4254.
  • 3Zambrano-Zaragoza J F, Romo-Mart i nez E J, Dur 6 n-Avela「Mde J, et al. Th17 cells in autoimmune and infectious diseases[J],Int J Inflam, 2014,2014:651503.
  • 4Rocha AM, Souza C, Rocha G A, et al. The levels o1 IL-17A and ofthe cytokines involved in Th17 cell commitment are increased inpatients with chronic immune thrombocytopenia[J].Haematologi-ca,2011,96(10):1560-1564.
  • 5无,侯明.成人原发免疫性血小板减少症诊断与治疗中国专家共识(2012年版)[J].中华血液学杂志,2012,33(11):975-977. 被引量:191
  • 6Provan D, Stasi R, Newland A C, et al. International consensus re-port on the investigation and management of primary immunethrombocytopenia[J]. Blood,2010,115(2): 168-186.
  • 7Olsson B, Andersson P O,Jernas M, et al. T-cell-mediated cyto-toxicity toward platelets in chronic idiopathic thrombocytopenicpurpura[J].Nat Med,2003,9(9): 1123-1124.
  • 8Yang L, Wang L, Zhao C H, et al. Contributions of TRAIL-mediat-ed megakaryocyte apoptosis to impaired megakaryocyte andplatelet production in immune thrombocytopenia[J], Blood, 2010,116(20):4307-4316.
  • 9Zhang X L, Peng J, Sun J Z, et al. De novo induction ofplatelet-specific CD4 (+)CD25 (+) regulatory T cells from CD4(+)CD25 (-) cells in patients with idiopathic thrombocytopenic pur-pura[J], Blood, 2009,113(11):2568-2577.
  • 10Doreau A, Belot A, Bastid J, et al. Interleukin 17 acts in synergywith Z cell-activating factor to influence B cell biology and thepathophysiology of systemic lupus erythematosus [J]. Nat Im-munol, 2009,10(7):778-785.

共引文献190

同被引文献14

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部